The JASMINE trial showed nipocalimab's efficacy in SLE, meeting primary and secondary endpoints, including steroid sparing ...

Subcutaneous anifrolumab (Saphnelo) added to standard therapy significantly improves treatment outcomes in patients with ...

Hydroxychloroquine has long been a foundational therapy in SLE because of its immunomodulatory effects and its role in ...

Imaavy will now progress to Phase III in SLE, though it will face strong competition from SLE market leader, Benlysta, if ...

Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...

Universitätsmedizin Berlin is astounded by the huge improvement seen in a female patient with severe systemic lupus erythematosus (SLE) after being treated with the cancer medication teclistamab. Not ...

Low baseline 25 (OH)D levels are associated with higher mortality and cardiovascular event risks among patients with systemic lupus erythematosus (SLE), with evidence of a U-shaped relationship ...

Objectives To examine the association between social determinants of health (SDH) and outcomes in systemic lupus ...

Study finds that consuming more caffeine may improve heart health. Study: Caffeine improves systemic lupus erythematosus endothelial dysfunction by promoting endothelial progenitor cells survival.

First Nations, Métis and Inuit people with primary biliary cholangitis—a debilitating autoimmune liver disease—have more advanced symptoms at diagnosis and worse long-term outcomes than others in ...